WallStSmart

Diversified Healthcare Trust (DHC) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

Diversified Healthcare Trust stock (DHC) is currently trading at $6.86. Diversified Healthcare Trust PS ratio (Price-to-Sales) is 1.06. Analyst consensus price target for DHC is $7.25. WallStSmart rates DHC as Sell.

  • DHC PE ratio analysis and historical PE chart
  • DHC PS ratio (Price-to-Sales) history and trend
  • DHC intrinsic value — DCF, Graham Number, EPV models
  • DHC stock price prediction 2025 2026 2027 2028 2029 2030
  • DHC fair value vs current price
  • DHC insider transactions and insider buying
  • Is DHC undervalued or overvalued?
  • Diversified Healthcare Trust financial analysis — revenue, earnings, cash flow
  • DHC Piotroski F-Score and Altman Z-Score
  • DHC analyst price target and Smart Rating
DHC

Diversified Healthcare Trust

NASDAQREAL ESTATE
$6.86
$0.15 (2.24%)
52W$1.98
$7.66
Target$7.25+5.7%

📊 No data available

Try selecting a different time range

WallStSmart

Smart Analysis

Diversified Healthcare Trust (DHC) · 9 metrics scored

Smart Score

40
out of 100
Grade: F
Hold
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Strong fundamentals in price/sales, price/book, institutional own.. Concerns around return on equity and operating margin. Mixed signals suggest waiting for clearer direction before acting.

Diversified Healthcare Trust (DHC) Key Strengths (3)

Avg Score: 9.3/10
Price/BookValuation
0.9810/10

Trading below book value, meaning the market prices it less than net assets

Institutional Own.Quality
79.66%10/10

79.66% of shares held by major funds and institutions

Price/SalesValuation
1.068/10

Paying $1.06 for every $1 of annual revenue

Supporting Valuation Data

Price/Sales (TTM)
1.056
Undervalued
EV/Revenue
2.551
Undervalued

Diversified Healthcare Trust (DHC) Areas to Watch (6)

Avg Score: 1.8/10
Return on EquityProfitability
-15.80%0/10

Company is destroying shareholder value

Operating MarginProfitability
-2.93%0/10

Losing money on operations

EPS GrowthGrowth
-68.40%0/10

Earnings declining -68.40%, profits shrinking

Profit MarginProfitability
-18.60%0/10

Company is losing money with a negative profit margin

Market CapQuality
$1.62B5/10

Small-cap company with higher risk but more growth potential

PEG RatioValuation
1.896/10

Growth is fairly priced, not cheap, not expensive

Diversified Healthcare Trust (DHC) Detailed Analysis Report

Overall Assessment

This company scores 40/100 in our Smart Analysis, earning a F grade. Out of 9 metrics analyzed, 3 register as strengths (avg 9.3/10) while 6 fall into concern territory (avg 1.8/10). The category breakdown reveals uneven performance, with some areas requiring attention.

The Bull Case

The strongest argument centers on Price/Book, Institutional Own., Price/Sales. Valuation metrics including Price/Sales (1.06), Price/Book (0.98) suggest the stock is attractively priced.

The Bear Case

The primary concerns are Return on Equity, Operating Margin, EPS Growth. Some valuation metrics including PEG Ratio (1.89) suggest expensive pricing. Growth concerns include EPS Growth at -68.40%, which may limit upside. Profitability pressure is visible in Return on Equity at -15.80%, Operating Margin at -2.93%, Profit Margin at -18.60%.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -15.80% needing improvement to support the investment thesis. Third, growth sustainability, with EPS Growth at -68.40% needing to reaccelerate.

Risk Considerations

Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

DHC Price-to-Sales(PS) Ratio Chart

Historical valuation based on market cap ÷ trailing 12-month revenue

DHC's Price-to-Sales ratio of 1.06x trades at a deep discount to its historical average of 13.45x (0th percentile). The current valuation is 97% below its historical high of 36.32x set in Dec 2006, and 0% above its historical low of 1.06x in Mar 2026.

Compare DHC with Competitors

Top REIT - HEALTHCARE FACILITIES stocks by market cap

Compare any two stocks →

WallStSmart Analysis Synopsis

Data-driven financial summary for Diversified Healthcare Trust (DHC) · REAL ESTATEREIT - HEALTHCARE FACILITIES

The Big Picture

Diversified Healthcare Trust is in a turnaround phase, with management focused on restoring profitability. The company is currently unprofitable, posting a -18.6% profit margin.

Key Findings

Cash Flow Positive

Generating 28M in free cash flow and 28M in operating cash flow. Earnings are translating into actual cash generation.

Operating at a Loss

The company is unprofitable with a -18.6% profit margin. The path to breakeven will be the key catalyst.

What to Watch Next

Volatility is elevated with a beta of 2.39, so expect amplified moves relative to the broader market.

Debt management: total debt of 2.7B is significantly higher than cash (201M). Monitor refinancing risk.

Sector dynamics: monitor REIT - HEALTHCARE FACILITIES industry trends, competitive moves, and regulatory changes that could impact Diversified Healthcare Trust.

Bottom Line

Diversified Healthcare Trust is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.

This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Insider Transactions

Loading insider activity...

About Diversified Healthcare Trust(DHC)

Exchange

NASDAQ

Sector

REAL ESTATE

Industry

REIT - HEALTHCARE FACILITIES

Country

USA

DHC is a real estate investment trust, or REIT, that owns medical offices and life science properties, senior communities and wellness centers throughout the United States. The company is headquartered in Newton, MA.

Visit Diversified Healthcare Trust (DHC) Website
TWO NEWTON PLACE, NEWTON, MA, UNITED STATES, 02458-1634